The fasting insulin test measures the concentration of insulin in your blood after at least an 8-hour fast. The optimal value is under 10 microIU/mL, the conventional normal range is under 25, and values above 25 suggest insulin resistance. The test is not used to diagnose diabetes but is a key marker of insulin resistance and the main input to the HOMA-IR calculation. Most useful in PCOS, metabolic syndrome, fatty liver, and prediabetes evaluation.
What Fasting Insulin Measures
After an overnight fast, your pancreas continues to secrete a low level of insulin called basal insulin secretion. This baseline reflects how much insulin your beta cells need to release to keep fasting glucose normal — and that requirement depends on how insulin-resistant your tissues are. Higher insulin resistance demands more basal insulin to overcome it.
Fasting insulin therefore acts as an inverse marker of insulin sensitivity:
- Low fasting insulin with normal glucose: excellent insulin sensitivity (or, rarely, beta-cell failure)
- High fasting insulin with normal glucose: insulin resistance with adequate compensation
- High fasting insulin with elevated glucose: insulin resistance with beginning beta-cell decompensation
- Low fasting insulin with elevated glucose: beta-cell failure (advanced T2D or T1D)
Reference Ranges
| Fasting insulin (microIU/mL) | Interpretation | Implication |
|---|---|---|
| Less than 5 | Very low / optimal | Highly insulin-sensitive (or beta-cell failure if glucose high) |
| 5 to 10 | Optimal | Good insulin sensitivity |
| 10 to 15 | Borderline / early insulin resistance | Consider lifestyle changes; monitor |
| 15 to 25 | Within “normal” but suboptimal | Likely early insulin resistance |
| 25 to 40 | Insulin resistance | Active metabolic dysfunction |
| Greater than 40 | Severe insulin resistance | Common in PCOS, severe NAFLD, metabolic syndrome |
| Greater than 100 | Extreme | Investigate insulin resistance syndromes, insulinoma |
Reference ranges differ across labs; many US labs use a wide “normal” of 2 to 25 microIU/mL. Optimal levels per integrative and metabolic specialists are tighter (under 10).
When the Fasting Insulin Test Is Ordered
| Clinical situation | Why fasting insulin helps |
|---|---|
| Suspected insulin resistance with normal glucose | Detects early metabolic dysfunction |
| Polycystic ovary syndrome (PCOS) evaluation | Documents insulin resistance driving PCOS |
| Non-alcoholic fatty liver disease (NAFLD) | Insulin resistance is a core driver |
| Metabolic syndrome workup | Quantifies the resistance component |
| Calculating HOMA-IR | Required input |
| Prediabetes risk stratification | Identifies higher-risk insulin-resistant prediabetes |
| Children/adolescents with obesity | Screens for early T2D risk |
| Lipoatrophic diabetes or rare insulin-resistance syndromes | Confirms diagnosis |
How the Test Is Performed
- Sample: serum or plasma from a routine venous blood draw
- Fasting required? Yes — at least 8 hours, ideally 10 to 12; water is allowed
- Timing: typically drawn first thing in the morning, before any food, coffee, or medication that affects glucose
- Assay platforms: chemiluminescent immunoassay (CLIA) or ECLIA; some specialty labs offer mass spectrometry insulin
- Turnaround: typically 1 to 3 days at commercial labs
- Cost: 30 to 80 dollars self-pay; covered with appropriate clinical indication
- Pair with fasting glucose: the two together let you compute HOMA-IR (and HOMA-β)
Fasting Insulin and HOMA-IR
The single most common downstream use of fasting insulin is to compute the HOMA-IR (Homeostasis Model Assessment of Insulin Resistance), introduced by Matthews and colleagues in 1985:
- Formula (US units, mg/dL): HOMA-IR = (fasting insulin in microIU/mL × fasting glucose in mg/dL) / 405
- Formula (SI units, mmol/L): HOMA-IR = (fasting insulin in mIU/L × fasting glucose in mmol/L) / 22.5
| HOMA-IR | Interpretation |
|---|---|
| Less than 1.0 | Optimal insulin sensitivity |
| 1.0 to 2.0 | Normal |
| 2.0 to 2.5 | Early insulin resistance |
| 2.5 to 5.0 | Significant insulin resistance |
| Greater than 5.0 | Severe insulin resistance |
Limitations of Fasting Insulin Testing
- Assay variability: commercial insulin assays differ in standardization. Compare same-lab values when monitoring.
- Pulsatile secretion: insulin is released in bursts every 5 to 10 minutes — a single blood draw can land at a peak or trough, giving noisy results.
- Insulin therapy: if you inject insulin, fasting insulin reflects injected plus endogenous and is not interpretable for resistance.
- Insulin antibodies: previous insulin exposure can produce antibodies that interfere with the assay (raise or lower the reading).
- Beta-cell failure confound: in advanced type 2 diabetes, fasting insulin can be low despite severe resistance — paradoxically because beta cells are exhausted.
- Diurnal variation: insulin levels vary with sleep, stress, and timing — standardize the draw to early morning fasted.
- Recent exercise: heavy exercise the day before can transiently lower fasting insulin.
Comparison to Other Insulin Resistance Markers
| Test | Captures | Advantage | Limitation |
|---|---|---|---|
| Fasting insulin | Basal insulin tone | Simple, inexpensive | Pulsatile noise; assay variability |
| HOMA-IR | Resistance index | Validated and widely used | Same insulin limitations apply |
| QUICKI | Reciprocal log of insulin × glucose | More linear at low values | Same limitations as HOMA |
| Fasting C-peptide | Endogenous insulin | Not affected by injected insulin | Renal clearance interferes |
| OGTT with insulin curve | Dynamic response | More physiological | Time-consuming; not standardized |
| Hyperinsulinemic-euglycemic clamp | Gold standard | Most accurate | Research only; expensive |
What to Do With a High Fasting Insulin Result
- Confirm with a repeat fasting test on a separate morning to rule out single-draw noise.
- Calculate HOMA-IR with the simultaneous fasting glucose.
- Evaluate for the underlying drivers — visceral obesity, sedentary lifestyle, ultra-processed diet, poor sleep, chronic stress, NAFLD, PCOS.
- Implement evidence-based lifestyle interventions — reduce refined carbs, add fiber and protein, increase resistance and aerobic exercise, lose 5 to 10 percent of body weight, improve sleep.
- Reassess fasting insulin and HOMA-IR after 3 to 6 months of intervention.
- If insulin remains very high despite lifestyle changes, talk to your doctor about metformin, GLP-1 receptor agonists, or other pharmacologic approaches.
Related Reading
See our broader guides on detection of prediabetes, HOMA-IR calculator, c-peptide testing, is prediabetes reversible, and A1C levels.
The Bottom Line
The fasting insulin test measures basal insulin secretion after an overnight fast and is a useful — though not perfect — marker of insulin resistance. Optimal values are under 10 microIU/mL; the conventional normal range stretches up to 25 but values above 10 to 15 already suggest early insulin resistance. The test is not used to diagnose diabetes but is a key input to HOMA-IR and a helpful tool in evaluating PCOS, fatty liver, metabolic syndrome, and prediabetes. Limitations include assay variability, pulsatile secretion noise, and beta-cell-failure confounding in advanced diabetes. If your fasting insulin is high, focus on the lifestyle interventions that improve insulin sensitivity, and reassess after a few months. Talk to your doctor about whether this test fits your overall metabolic workup.
